Cargando…

Overview of coronavirus pandemic

During the last months of 2019, numerous cases of respiratory illness such as pneumonia and acute respiratory distress syndrome were described in Wuhan, the capital city of Hubei province in China. At the same time, several research groups identified and reported the etiological agent, that included...

Descripción completa

Detalles Bibliográficos
Autores principales: Artiga-Sainz, Laura Margarita, Ibáñez-Navarro, Adrián, Morante-Ruiz, Miguel, Bilbao, Juan Sánchez-Verde, Rodríguez de Lema-Tapetado, Guido, Sarria-Santamera, Antonio, Quintana-Díaz, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300555/
http://dx.doi.org/10.1016/B978-0-323-91172-6.00013-3
_version_ 1784751240649900032
author Artiga-Sainz, Laura Margarita
Ibáñez-Navarro, Adrián
Morante-Ruiz, Miguel
Bilbao, Juan Sánchez-Verde
Rodríguez de Lema-Tapetado, Guido
Sarria-Santamera, Antonio
Quintana-Díaz, Manuel
author_facet Artiga-Sainz, Laura Margarita
Ibáñez-Navarro, Adrián
Morante-Ruiz, Miguel
Bilbao, Juan Sánchez-Verde
Rodríguez de Lema-Tapetado, Guido
Sarria-Santamera, Antonio
Quintana-Díaz, Manuel
author_sort Artiga-Sainz, Laura Margarita
collection PubMed
description During the last months of 2019, numerous cases of respiratory illness such as pneumonia and acute respiratory distress syndrome were described in Wuhan, the capital city of Hubei province in China. At the same time, several research groups identified and reported the etiological agent, that included within the Coronaviridae family and the order Nidovirales, named SARS-CoV-2. Subsequently, the pathological and clinical status caused by the pathogen is commonly known as Coronavirus disease 2019 (COVID-19). In a short period, the outbreak of emerging spread across the world. Therefore the World Health Organization declared a public health emergency of international concern on January 30, 2020, and as a pandemic on March 11, 2020. Many different public health and epidemiological studies have been published since the COVID-19 outbreak, but fatality rates (those that relate the number of cases to mortality) are difficult to assess with certainty. Mean and median case-fatality rates worldwide are near to 3% and 2%, respectively. The median infection fatality calculated from serologic prevalence varies from 0.00% to 1.63% but is mostly estimated between 0.27% and 0.9%. These indexes are influenced by geographic location, socioeconomic status, sex, age, and health conditions, among others.
format Online
Article
Text
id pubmed-9300555
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-93005552022-07-21 Overview of coronavirus pandemic Artiga-Sainz, Laura Margarita Ibáñez-Navarro, Adrián Morante-Ruiz, Miguel Bilbao, Juan Sánchez-Verde Rodríguez de Lema-Tapetado, Guido Sarria-Santamera, Antonio Quintana-Díaz, Manuel Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection Article During the last months of 2019, numerous cases of respiratory illness such as pneumonia and acute respiratory distress syndrome were described in Wuhan, the capital city of Hubei province in China. At the same time, several research groups identified and reported the etiological agent, that included within the Coronaviridae family and the order Nidovirales, named SARS-CoV-2. Subsequently, the pathological and clinical status caused by the pathogen is commonly known as Coronavirus disease 2019 (COVID-19). In a short period, the outbreak of emerging spread across the world. Therefore the World Health Organization declared a public health emergency of international concern on January 30, 2020, and as a pandemic on March 11, 2020. Many different public health and epidemiological studies have been published since the COVID-19 outbreak, but fatality rates (those that relate the number of cases to mortality) are difficult to assess with certainty. Mean and median case-fatality rates worldwide are near to 3% and 2%, respectively. The median infection fatality calculated from serologic prevalence varies from 0.00% to 1.63% but is mostly estimated between 0.27% and 0.9%. These indexes are influenced by geographic location, socioeconomic status, sex, age, and health conditions, among others. 2022 2022-07-15 /pmc/articles/PMC9300555/ http://dx.doi.org/10.1016/B978-0-323-91172-6.00013-3 Text en Copyright © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Artiga-Sainz, Laura Margarita
Ibáñez-Navarro, Adrián
Morante-Ruiz, Miguel
Bilbao, Juan Sánchez-Verde
Rodríguez de Lema-Tapetado, Guido
Sarria-Santamera, Antonio
Quintana-Díaz, Manuel
Overview of coronavirus pandemic
title Overview of coronavirus pandemic
title_full Overview of coronavirus pandemic
title_fullStr Overview of coronavirus pandemic
title_full_unstemmed Overview of coronavirus pandemic
title_short Overview of coronavirus pandemic
title_sort overview of coronavirus pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300555/
http://dx.doi.org/10.1016/B978-0-323-91172-6.00013-3
work_keys_str_mv AT artigasainzlauramargarita overviewofcoronaviruspandemic
AT ibaneznavarroadrian overviewofcoronaviruspandemic
AT moranteruizmiguel overviewofcoronaviruspandemic
AT bilbaojuansanchezverde overviewofcoronaviruspandemic
AT rodriguezdelematapetadoguido overviewofcoronaviruspandemic
AT sarriasantameraantonio overviewofcoronaviruspandemic
AT quintanadiazmanuel overviewofcoronaviruspandemic